???global.info.a_carregar???
Rita Oliveira has a master's degree in Pharmaceutical Sciences from the Faculty of Pharmacy, University of Coimbra. During her academic training she has done four research internships (group of Cellular and Molecular Pharmacology, IBILI; group of Mitochondria and Neurodegenerative Diseases, CNC; group of Medicinal Chemistry and Drug Discovery, FFUC; and Research and Innovation department, Bluepharma Pharmaceutical Industry). After completing her academic training, she joined the research and innovation department of Bluepharma Pharmaceutical Industry, where she worked as a formulation scientist in the search for and development of innovative drug delivery systems. Currently, she is a PhD student in the Medicinal Chemistry and Drug Discovery group at the Faculty of Pharmacy, University of Coimbra. Her research is mainly focused in the oncology field and combines computer-aided drug design methodologies with molecular biology to speed up the drug discovery process.
Ler resumo completo ↓
Identificação

Identificação pessoal

Nome completo
Rita Isabel Fernandes de Oliveira

Nomes de citação

  • Rita Isabel Oliveira

Identificadores de autor

Ciência ID
961D-10DE-DF9F
ORCID iD
0000-0002-1511-4364

Endereços de correio eletrónico

  • rita.oliveira@cnc.uc.pt (Profissional)
Formação
Grau Classificação
2022/01/01 - 2026/01/01
Em curso
 PhD Student (Pharmaceutical Chemistry Laboratory - Medicinal Chemistry and Drug Discovery group) (Doutoramento)
Universidade de Coimbra Faculdade de Farmácia, Portugal
2015/09/14 - 2020/09/29
Concluído
 Integrated Master's in Pharmaceutical Sciences (Mestrado integrado)
Universidade de Coimbra Faculdade de Farmácia, Portugal
"Novos horizontes terapêuticos para o cancro da mama: papel da medicina de precisão" (TESE/DISSERTAÇÃO)
 18 valores
Produções

Publicações

Artigo em revista
  1. Tiago O. Pereira; Maryam Abbasi; Rita I. Oliveira; Romina A. Guedes; Jorge A. R. Salvador; Joel P. Arrais. "Artificial intelligence for prediction of biological activities and generation of molecular hits using stereochemical information". Journal of Computer-Aided Molecular Design (2023): http://dx.doi.org/10.1007/s10822-023-00539-9.
    10.1007/s10822-023-00539-9
  2. Laura D. Carreira; Rita I. Oliveira; Vânia M. Moreira; Jorge A. R. Salvador. "Ubiquitin-specific protease 7 (USP7): an emerging drug target for cancer treatment". Expert Opinion on Therapeutic Targets (2023): https://doi.org/10.1080/14728222.2023.2266571.
    10.1080/14728222.2023.2266571
  3. Rita Isabel Oliveira. "Highlights in USP7 inhibitors for cancer treatment". Frontiers in Chemistry 10 (2022): http://dx.doi.org/10.3389/fchem.2022.1005727.
    10.3389/fchem.2022.1005727
  4. Rita Isabel Oliveira. "Deep generative model for therapeutic targets using transcriptomic disease-associated data—USP7 case study". Briefings in Bioinformatics 23 4 (2022): http://dx.doi.org/10.1093/bib/bbac270.
    10.1093/bib/bbac270
Poster em conferência
  1. Rita Isabel Oliveira. "Towards the discovery of novel ubiquitin specific protease 7 (USP7) Inhibitors: an integrated protocol of pharmacophore modelling and virtual screening". Trabalho apresentado em 15th National Organic Chemistry Meeting (15ENQO) & 8th National Medicinal Chemistry Meeting (8ENQT), Faro, Portugal, 2024.
  2. Rita Isabel Oliveira. "Discovery of novel inhibitors of ubiquitin specific protease 7 (USP7) through structure-based virtual screening". Trabalho apresentado em EUROPIN Summer School on Drug Design, Vienna, Austria, 2023.